Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free INM Stock Alerts

InMed Pharmaceuticals (INM) Institutional Ownership

InMed Pharmaceuticals logo
$0.65 -0.05 (-6.66%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$0.65 0.00 (-0.46%)
As of 05/8/2026 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for InMed Pharmaceuticals (NASDAQ:INM)

Current
Institutional Ownership
Percentage
20.12%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$526.40K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$19.47K
Get INM Insider Trade Alerts

Want to know when executives and insiders are buying or selling InMed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

INM Institutional Buying and Selling by Quarter

InMed Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Sabby Management LLC201,633$214K0.3%-8.3%6.905%
11/14/2025Virtu Financial LLC20,369$45K0.0%N/A0.727%
11/14/2025Sabby Management LLC219,998$482K0.6%N/A7.857%
2/14/2025AdvisorShares Investments LLC38,460$177K0.0%-94.8%5.342%
2/13/2024Armistice Capital LLC205,968$86K0.0%N/A3.916%
11/14/2022Armistice Capital LLC90,000$593K0.0%-90.6%9.605%
5/17/2022Empery Asset Management LP61,741$58K0.3%N/A0.437%


INM Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of InMed Pharmaceuticals shares: Sabby Management LLC ($214K), and AdvisorShares Investments LLC ($177K), Virtu Financial LLC ($45K).Learn more on InMed Pharmaceuticals' institutional investors.

20.12% of InMed Pharmaceuticals' stock is owned by institutional investors. Learn more on INM's institutional investor holdings.

The following institutional investors have purchased InMed Pharmaceuticals' stock in the last 24 months: Sabby Management LLC ($220.00K), and Virtu Financial LLC ($20.37K).

Institutional investors have bought a total of 240,367 shares in the last 24 months. This purchase volume represents approximately $526.40K in transactions.

The following institutional investors have sold InMed Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($18.37K).

Institutional investors have sold a total of 18,365 shares in the last 24 months. This volume of shares sold represents approximately $19.47K in transactions.


Related Companies

This page (NASDAQ:INM) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel